Rockefeller Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Buy
5,244
+1,570
+43% +$56.5K ﹤0.01% 2498
2026
Q1
$90.1K Buy
3,674
+866
+31% +$20.5K ﹤0.01% 2937
2025
Q4
$69.7K Buy
2,808
+286
+11% +$7.59K ﹤0.01% 2909
2025
Q3
$71.5K Buy
+2,522
New +$68.3K ﹤0.01% 2743
2023
Q1
Sell
-2,427
Closed -$71K 3945
2022
Q4
$71K Hold
2,427
﹤0.01% 2212
2022
Q3
$94K Sell
2,427
-6
-0.2% -$275 ﹤0.01% 2027
2022
Q2
$93K Buy
2,433
+2,423
+24,230% +$92.2K ﹤0.01% 1988
2022
Q1
$0 Sell
10
-1
-9% -$52 ﹤0.01% 4094
2021
Q4
$0 Buy
+11
New +$904 ﹤0.01% 4020

Other funds holding ASTH

Rockefeller Capital Management's ASTH Position: Q2 2026 in Review

Rockefeller Capital Management increased its Astrana Health (ASTH) stake by 43% in Q2 2026, buying an estimated $56.5K and bringing the position to 5,244 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #2498.

Rockefeller Capital Management first reported a position in ASTH in Q4 2021 and has held it in 9 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Rockefeller Capital Management held 5,244 shares of Astrana Health worth $243K as of Q2 2026.
  • Rockefeller Capital Management bought 1,570 Astrana Health shares in Q2 2026, an estimated $56.5K.
  • Astrana Health made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2498 holding.
  • Rockefeller Capital Management first reported a position in Astrana Health in Q4 2021 and has held it in 9 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.